Meningitis, Cryptococcal: Clinical Trials

19 trials for Meningitis, Cryptococcal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 4 unknown. 19 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable19Completed 15, Unknown 4

Follow Meningitis, Cryptococcal: new trials by email Literature Review of Meningitis, Cryptococcal trials Research Report on Meningitis, Cryptococcal

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Point of Care Tests to Identify Opportunistic Infections in Advanced HIV Patients in Mexico City
Histoplasma Urine Antigen Lateral Flow Antigen test, Cryptococcal Lateral Flow Antigen test, Tuberculosis-lipoarabinomannan Lateral Flow Antigen test - Acquired Immunodeficiency Syndrome, Histoplasmosis AIDS
Not applicableUnknownNational Institute of Respiratory Diseases, Mexico2112023-04-012023-01-17
Clinical Study of ABCD in the Treatment of Cryptococcal Meningitis
Amphotericin B Colloidal Dispersion, flucytosine, fluconazole - Cryptococcal Meningitis
Not applicableUnknownPeking Union Medical College Hospital302022-08-222022-07-22
Driving Reduced AIDS-associated Meningo-encephalitis Mortality
DREAMM - AIDS-Related Opportunistic Infections, Meningo-encephalitis
Not applicableCompletedSt George's, University of London4952016-04-232022-05-04
Pre-Antiretroviral Therapy (ART) Cryptococcal Antigen Screening in AIDS
Fluconazole, Antiretroviral therapy - Cryptococcal Meningitis
Not applicableUnknownANRS, Emerging Infectious Diseases1862015-07-012018-03-15
Liposomal Amphotericin B for the Treatment of Cryptococcal Meningitis
Liposomal amphotericin B, Amphotericin B-deoxycholate - Cryptococcal Meningitis
Not applicableUnknownTTY Biopharm842011-02-012014-05-12
Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa
Fluconazole, Fixed dose - Stavudine, lamivudine and Nevirapine, Fixed dose - Stavudine, Lamivudine, Nevirapine - Cryptococcal Meningitis, HIV Infections
Not applicableCompletedUniversity of Zimbabwe542006-10-012016-07-18
An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
Fluconazole - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedPfizer2005-06-24
A Randomized Double Blind Protocol Comparing Amphotericin B With Flucytosine to Amphotericin B Alone Followed by a Comparison of Fluconazole and Itraconazole in the Treatment of Acute Cryptococcal Meningitis
Itraconazole, Flucytosine, Fluconazole - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)4002021-11-02
Pilot Study of Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
Fluconazole - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedPfizer2005-06-24
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Maintenance Treatment for the Prevention of Relapse of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome
Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedPfizer2005-06-24
Safety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency Syndrome
Amphotericin B, Lipid-based, Amphotericin B - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedLiposome2005-06-24
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients Who Have Not Had Success With Amphotericin B
Fluconazole - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedPfizer2005-06-24
Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
Flucytosine, Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedNational Institute of Allergy and Infectious Diseases (NIAID)1202011-03-14
Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
Fluconazole - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedPfizer2005-06-24
A Pilot Study of Fluconazole Plus Flucytosine for the Treatment of AIDS Patients With Acute Cryptococcal Meningitis.
Flucytosine, Fluconazole - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedPfizer642005-06-24
A Comparison of Fluconazole and Amphotericin B in the Treatment of Cryptococcal Meningitis
Flucytosine, Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedPfizer2005-06-24
A Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedPfizer2005-06-24
Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis
Flucytosine, Fluconazole, Amphotericin B - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedPfizer2005-06-24
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS
Fluconazole - Meningitis, Cryptococcal, HIV Infections
Not applicableCompletedPfizer2005-06-24

Narrower conditions

Acquired Immunodeficiency Syndrome (14)  ·  HIV Infections (14)  ·  Meningitis (14)  ·  Cryptococcosis (13)  ·  AIDS-Related Opportunistic Infections (12)  ·  Brain Diseases (1)  ·  Latent Tuberculosis (1)  ·  Meningitis, Bacterial (1)  ·  Toxoplasmosis, Cerebral (1)  ·  Tuberculosis, Meningeal (1)

Broader conditions

Bacterial Infections and Mycoses (19)  ·  Central Nervous System Diseases (19)  ·  Central Nervous System Fungal Infections (19)  ·  Central Nervous System Infections (19)  ·  Infections (19)  ·  Meningitis, Fungal (19)  ·  Mycoses (19)  ·  Nervous System Diseases (19)  ·  Neuroinflammatory Diseases (19)  ·  Blood-Borne Infections (16)  ·  Communicable Diseases (16)  ·  Immune System Diseases (16)  ·  Immunologic Deficiency Syndromes (16)  ·  Lentivirus Infections (16)  ·  RNA Virus Infections (16)

Interventions

Fluconazole (15)  ·  Amphotericin B (9)  ·  Flucytosine (6)  ·  Antiretroviral Therapy, Highly Active (1)  ·  Injections (1)  ·  Itraconazole (1)  ·  Lamivudine (1)  ·  Nevirapine (1)  ·  Stavudine (1)  ·  amphotericin B, deoxycholate drug combination (1)  ·  liposomal amphotericin B (1)

Sponsors

Pfizer (10)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  Liposome (1)  ·  National Institute of Respiratory Diseases, Mexico (1)  ·  Peking Union Medical College Hospital (1)  ·  St George's, University of London (1)  ·  TTY Biopharm (1)  ·  University of Zimbabwe (1)

Countries

United States (13)  ·  Canada (3)  ·  Cameroon (2)  ·  China (1)  ·  Malawi (1)  ·  Mexico (1)  ·  Taiwan (1)  ·  Tanzania (1)  ·  Zimbabwe (1)

Top investigators

Angela Loyse, MD (1)  ·  Armstrong D (1)  ·  Azure T Makadzange, MD, DPhil (1)  ·  Charles Kouanfack, MD, PhD (1)  ·  Chiratidzo E Ndhlovu, MBChB, FRCP (1)  ·  Elvis Temfack, MD, MSc (1)  ·  James Hakim, MBChB, FRCP (1)  ·  Olivier Lortholary, MD, PhD (1)  ·  Saag M (1)  ·  Taisheng Li, PhD (1)  ·  Thomas Harrison, MD (1)  ·  Yee-chun Chen, MD (1)  ·  van der Horst C (1)

Results publications

PMID 20415574, PMID 26768369, PMID 37802567